HERTFORDSHIRE, England and PITTSBURGH, May 26, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) a leading global pharmaceutical company, today announced that the Company will present at the Goldman Sachs 37th Annual Global Healthcare Conference on Tuesday, June 7, 2016, in Rancho Palos Verdes, CA. The presentation is scheduled to begin at 2:40 p.m. PT / 5:40 p.m. ET.
Interested parties can access a live webcast of the presentation via the investor relations section of Mylan's website at http://mylan.com/investors.
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,400 generic and branded pharmaceuticals, including antiretroviral therapies on which approximately 50% of people being treated for HIV/AIDS in the developing world depend. We market our products in approximately 165 countries and territories. Our global R&D and manufacturing platform includes more than 50 facilities, and we are one of the world's largest producers of active pharmaceutical ingredients. Every member of our nearly 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at mylan.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mylan-to-present-at-goldman-sachs-37th-annual-global-healthcare-conference-300275589.html
SOURCE Mylan N.V.